FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

CIPLA

816.25
-16.55 (-1.99%)
Updated 03:29 21/01 IST

CIPLA Buy or Sell - FrontPage Forums

7 Users have submitted 9 trade ideas of Rs. 909,450.7 for CIPLA
Disclaimer
78% Bullish
22% Bearish

CIPLA Buy or Sell - Brokerage Reports

No. of reports in last year
11
No. of analysts
5
Average Consensus Forecast
720.64
Consensus Potential
-21.30%
See CIPLA Share Price Targets >>

CIPLA Ratings

Long term CIPLA rating by FrontPage users
3.6/5 (5 Ratings)
Find answers to all your questions on live CIPLA message board: Is CIPLA buy or sell? Should I buy CIPLA shares? Why are CIPLA shares falling? Should I invest in CIPLA stock?

  1. Home
  2. CIPLA Forum

CIPLA Share Price Discussion


Type
Buy
Instrument
CIPLA
Entry Price
₹810
Price@Trade
₹809.75
Target Price
₹860
Stop Price
₹760
Valid Till
Feb 19, 2021 3:20 AM
Margin
₹202,500 approx for 250 Qty
Status
Active
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Yesterday 8:42 AM

Update
Trade Entered
Entry Price
₹810

Type
Sell
Instrument
CIPLA
Entry Price
₹811
Price@Trade
₹810.1
Target Price
₹751
Stop Price
₹861
Valid Till
Feb 19, 2021 3:20 AM
Margin
₹202,750 approx for 250 Qty
Status
Active
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Yesterday 8:42 AM

Update
Trade Entered
Entry Price
₹811

Type
Buy
Instrument
CIPLA JAN21 820 PE
Entry Price
₹13.6
Price@Trade
₹13.6
Target Price
₹35
Stop Price
₹0
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹17,680 approx for 1300 Qty
Status
Exited
Exit Price
₹18.5
Net P&L
+₹6,370 (+36.03%)
Like
Reply (1)
See all replies
Ravi Kumar @ravikumar-BJE7-Ujaw
Yesterday 8:23 AM

Update
Exited
Exit Price
₹18.5
Net P&L
+₹6,370 (+36.03%)
S
Reputation: -17,421 • Yesterday 6:53 AM

Type
Sell
Instrument
CIPLA JAN21 FUT
Entry Price
₹828.1
Price@Trade
₹828.1
Target Price
₹800
Stop Price
₹850
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹241,479.55 approx for 1300 Qty
Status
Exited
Exit Price
₹818.45
Net P&L
+₹12,545 (+5.2%)
Like
Reply (1)
See all replies
segui @SEGU
Yesterday 8:09 AM

Update
Exited
Exit Price
₹818.45
Net P&L
+₹12,545 (+5.2%)
Like
Reply
T
Reputation: -1,765 • Yesterday 4:21 AM

Type
Buy
Instrument
CIPLA
Entry Price
₹833.95
Price@Trade
₹833.95
Target Price
₹880
Stop Price
₹801
Valid Till
Feb 19, 2021 3:20 AM
Margin
₹83,395 approx for 100 Qty
Status
Active
Like
Reply
V
Reputation: -23,824 • Yesterday 3:10 AM

Type
Buy
Instrument
CIPLA JAN21 830 CE
Entry Price
₹15.2
Price@Trade
₹17
Target Price
₹25
Stop Price
₹14
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹19,760 approx for 1300 Qty
Status
Stoploss Hit
Exit Price
₹14
Net P&L
-₹1,560 (-7.89%)
Like
Reply (2)
See all replies
TrackerBot @trackerbot
Yesterday 5:44 AM

Update
Trade Entered
Entry Price
₹15.2
TrackerBot @trackerbot
Yesterday 6:38 AM

Update
Stoploss Hit
Exit Price
₹14
V
Reputation: -23,824 • Yesterday 3:04 AM

Type
Buy
Instrument
CIPLA JAN21 830 CE
Entry Price
₹18
Price@Trade
₹18.15
Target Price
₹25
Stop Price
₹16.5
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹23,400 approx for 1300 Qty
Status
Stoploss Hit
Exit Price
₹16.5
Net P&L
-₹1,950 (-8.33%)
Like
Reply (2)
See all replies
TrackerBot @trackerbot
Yesterday 3:06 AM

Update
Trade Entered
Entry Price
₹18
TrackerBot @trackerbot
Yesterday 3:07 AM

Update
Stoploss Hit
Exit Price
₹16.5
V
Reputation: -23,824 • Yesterday 3:03 AM

Type
Buy
Instrument
CIPLA JAN21 820 CE
Entry Price
₹23.85
Price@Trade
₹23.85
Target Price
₹31
Stop Price
₹17
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹62,010 approx for 2600 Qty
Status
Stoploss Hit
Exit Price
₹17
Net P&L
-₹17,810 (-28.72%)
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Yesterday 7:53 AM

Update
Stoploss Hit
Exit Price
₹17
J
Reputation: -29,086 • Yesterday 2:47 AM

Type
Buy
Instrument
CIPLA JAN21 820 CE
Entry Price
₹24.4
Price@Trade
₹24.4
Target Price
₹50
Stop Price
₹12
Valid Till
Jan 21, 2021 3:20 AM
Margin
₹31,720 approx for 1300 Qty
Status
Exited
Exit Price
₹23
Net P&L
-₹1,820 (-5.74%)
Like
Reply (1)
See all replies
John Marston @johnmarston
Yesterday 4:55 AM

Update
Exited
Exit Price
₹23
Net P&L
-₹1,820 (-5.74%)
S
Reputation: 5,133,761 • Yesterday 2:38 AM

INTRADAY
BUY CIPLA
ABOVE : 836
SL : 822
TARGET : OPEN
1
Reply

Type
Buy
Instrument
CIPLA
Entry Price
₹833.3
Price@Trade
₹833.35
Target Price
₹860
Stop Price
₹810  ₹820
Valid Till
Jan 21, 2021 3:20 AM  Jan 25, 2021 3:20 AM
Margin
₹83,330 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹820
Net P&L
-₹1,330 (-1.6%)
BTST SCANNER TRIAL
Like
Reply (4)
See all replies

Update
Stoploss Trailed
Price @ Update
₹833.55
Original SL
₹810
New SL
₹820

Update
Time Extended
Price @ Update
₹833.7
Original Time
Jan 21, 2021 3:20 AM
New Time
Jan 25, 2021 3:20 AM
TrackerBot @trackerbot
Yesterday 8:03 AM

Update
Stoploss Hit
Exit Price
₹820
Billion Club in CIPLA
BUY CIPLA JAN ABV 829 #CIPLA

#CIPLA ONCE EXIT LONG IN CIPLA JAN AT 833 BOOK PROFIT RS 5200
Like
Reply (4)
See all replies
Billion Club @100billionclub
Jan 20 11:02 AM

प्रीमियम खा रहा है सर
Sudip Singha @sudipsingha
Jan 20 11:23 AM

Sir primium up hoga kya ..kyuki abhi CIPLA 832+ main close hua ..kalse ajtak 32 point up hua cipla par premium 3.95 se 2.40 main aa gaya premium..Bcz maine 5.50 main buy kya hua hai 4 lot...Hold karu expry tak ya exit ho jau ?Bahut loss ho raha hai
Billion Club @100billionclub
Jan 20 11:44 AM

CIPLA - 1989757
Chek this sir i m already cipla 870 CE sell call di hui hai Or aap result dekho
V
Reputation: -23,824 • Jan 20 5:44 AM

Type
Buy
Instrument
CIPLA JAN21 830 CE
Entry Price
₹16.7
Price@Trade
₹16.7
Target Price
₹25
Stop Price
₹14
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹43,420 approx for 2600 Qty
Status
Exited
Exit Price
₹17.35
Net P&L
+₹1,690 (+3.89%)
Like
Reply (1)
See all replies
Vikram @vikram-r1LRmqGOP
Jan 20 8:55 AM

Update
Exited
Exit Price
₹17.35
Net P&L
+₹1,690 (+3.89%)
N
Reputation: -472 • Jan 20 4:14 AM

Type
Buy
Instrument
CIPLA FEB21 FUT
Entry Price
₹836
Price@Trade
₹836
Target Price
₹860
Stop Price
₹825
Valid Till
Jan 20, 2021 3:20 AM
Margin
₹241,267 approx for 1300 Qty
Status
Exited
Exit Price
₹832
Net P&L
-₹5,200 (-2.16%)
Like
Reply (1)
See all replies
Nirav @NHM10
Jan 20 5:04 AM

Update
Exited
Exit Price
₹832
Net P&L
-₹5,200 (-2.16%)
J
Reputation: -29,086 • Jan 20 3:07 AM

Type
Buy
Instrument
CIPLA JAN21 820 CE
Entry Price
₹22.5
Price@Trade
₹22.5
Target Price
₹40
Stop Price
₹15
Valid Till
Jan 20, 2021 3:20 AM
Margin
₹58,500 approx for 2600 Qty
Status
Validity Over
Exit Price
₹23.7
Net P&L
+₹3,120 (+5.33%)
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Jan 20 8:50 AM

Update
Validity Over
Exit Price
₹23.7
Net P&L
+₹3,120 (+5.33%)
Like
Reply (1)
See all replies
Billion Club @100billionclub
Jan 20 8:36 AM

ONCE EXIT LONG IN CIPLA JAN AT 833 BOOK PROFIT RS 5200
H
Reputation: -9,699 • Jan 20 2:56 AM

Type
Buy
Instrument
CIPLA JAN21 700 PE
Entry Price
₹0.2
Price@Trade
₹0.25
Target Price
₹0.45
Stop Price
₹0
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹2,600 approx for 13000 Qty
Status
Exited before entry
Like
Reply (1)
See all replies
Harshad @harshad-HJA2KLX0v
Yesterday 3:31 AM

Update
Exited before entry
Price @ Update
₹0.55
H
Reputation: -9,699 • Jan 19 8:57 AM

Type
Buy
Instrument
CIPLA JAN21 700 PE
Entry Price
₹0.2  ₹0.35
Price@Trade
₹0.35
Target Price
₹2
Stop Price
₹0
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹45,500 approx for 130000 Qty
Status
Exited
Exit Price
₹0.4
Net P&L
+₹6,500 (+14.29%)
Like
Reply (3)
See all replies
Harshad @harshad-HJA2KLX0v
Jan 19 8:58 AM

Update
Entry Price Modified
Price @ Update
₹0.35
Original Entry Price
₹0.2
New Entry Price
₹0.35
TrackerBot @trackerbot
Jan 19 9:00 AM

Update
Trade Entered
Entry Price
₹0.35
Harshad @harshad-HJA2KLX0v
Jan 20 3:25 AM

Update
Exited
Exit Price
₹0.4
Net P&L
+₹6,500 (+14.29%)
H
Reputation: -9,699 • Jan 19 8:57 AM

Type
Buy
Instrument
CIPLA JAN21 700 PE
Entry Price
₹0.25
Price@Trade
₹0.35
Target Price
₹1.25
Stop Price
₹0
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹325 approx for 1300 Qty
Status
Exited
Exit Price
₹0.4
Net P&L
+₹195 (+60%)
Like
Reply (2)
See all replies
TrackerBot @trackerbot
Jan 20 2:49 AM

Update
Trade Entered
Entry Price
₹0.25
Harshad @harshad-HJA2KLX0v
Jan 20 3:28 AM

Update
Exited
Exit Price
₹0.4
Net P&L
+₹195 (+60%)

Type
Buy
Instrument
CIPLA
Entry Price
₹822.35
Price@Trade
₹821.95
Target Price
₹900
Stop Price
₹800
Valid Till
Feb 19, 2021 3:20 AM
Margin
₹82,235 approx for 100 Qty
Status
Active
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Jan 19 7:26 AM

Update
Trade Entered
Entry Price
₹822.35
M
Reputation: 46,004 • Jan 19 7:03 AM

Type
Buy
Instrument
CIPLA JAN21 820 CE
Entry Price
₹21.45
Price@Trade
₹21.45
Target Price
₹50
Stop Price
₹0
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹27,885 approx for 1300 Qty
Status
Exited
Exit Price
₹24.4
Net P&L
+₹3,835 (+13.75%)
Like
Reply (1)
See all replies
Mohan M as MDT @mohanmMDT
Jan 20 4:20 AM

Update
Exited
Exit Price
₹24.4
Net P&L
+₹3,835 (+13.75%)

Type
Buy
Instrument
CIPLA
Entry Price
₹819
Price@Trade
₹818.75
Target Price
₹938
Stop Price
₹700
Valid Till
Jan 19, 2022 3:20 AM
Margin
₹81,900 approx for 100 Qty
Status
Exited
Exit Price
₹834.2
Net P&L
+₹1,520 (+1.86%)
Like
Reply (2)
See all replies
TrackerBot @trackerbot
Jan 19 6:53 AM

Update
Trade Entered
Entry Price
₹819
Saroj Bhanja @sarojbhanja
Jan 20 4:07 AM

Update
Exited
Exit Price
₹834.2
Net P&L
+₹1,520 (+1.86%)
H
Reputation: -9,699 • Jan 19 3:32 AM

Type
Buy
Instrument
CIPLA JAN21 700 PE
Entry Price
₹0.7  ₹0.55
Price@Trade
₹0.8
Target Price
₹1.2
Stop Price
₹0.4
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹2,860 approx for 5200 Qty
Status
Stoploss Hit
Exit Price
₹0.4
Net P&L
-₹780 (-27.27%)
Like
Reply (2)
See all replies
TrackerBot @trackerbot
Jan 19 5:29 AM

Update
Trade Entered
Entry Price
₹0.55
TrackerBot @trackerbot
Jan 19 8:48 AM

Update
Stoploss Hit
Exit Price
₹0.4
V
Reputation: -23,824 • Jan 19 3:13 AM

Type
Buy
Instrument
CIPLA JAN21 820 CE
Entry Price
₹22
Price@Trade
₹22.4
Target Price
₹23
Stop Price
₹21
Valid Till
Jan 19, 2021 3:20 AM
Margin
₹28,600 approx for 1300 Qty
Status
Stoploss Hit
Exit Price
₹21
Net P&L
-₹1,300 (-4.55%)
Like
Reply (2)
See all replies
TrackerBot @trackerbot
Jan 19 3:14 AM

Update
Trade Entered
Entry Price
₹22
TrackerBot @trackerbot
Jan 19 3:16 AM

Update
Stoploss Hit
Exit Price
₹21
Perfect Traders in CIPLA
INTRADAY FUTURE CALL ------------------ STOCK :...
1
Reply
Perfect Traders in CIPLA
INTRADAY FUTURE CALL ------------------ STOCK :...
2
Reply

INTRADAY FUTURE CALL
------------------
STOCK : #CIPLA
ABOVE - 807
TARGET 813,819,825
SL 801
.
BELOW - 795
TARGET 789,783,778
SL 801
1
Reply
N
Reputation: 10,343 • Jan 18 4:48 AM
Cipla Q3 PAT Seen Up 77.2% YoY To Rs. 351 Cr: Prabhudas Lilladher
Net Sales are expected to increase by 15.3 percent Y-o-Y (down 1.8 percent Q-o-Q) to Rs. 4,234.6 crore, according to Prabhudas Lilladher.
Moneycontrol
Like
Reply
N
Reputation: 10,343 • Jan 18 2:08 AM
Cipla Q3 PAT Seen Up 73.2% YoY To Rs. 608.1 Cr: ICICI Direct
Net Sales are expected to increase by 15.7 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs. 5,057.6 crore, according to ICICI Direct.
Moneycontrol
1
Reply

CIPLA - chart - 1971549
#CIPLA with Major Support and Resistance zones
1
Reply
A
Reputation: 2,909 • Jan 18 11:33 AM
Post by Akshay in IDX:NIFTY 50 community on FrontPage
NIFTY VIEW AS ON 16 JAN 2021 (Major Update on Nifty and Stock Portfolio) Intraday Pick for Monday !!Intraday Resistance Zone is 14500-14510I
FrontPage


NIFTY VIEW AS ON 18 JAN 2020 (Intraday Bearish and Profit Bookings)

As we have seen that we were considering EXIT from INDIGO and BIOCON after profit booking and we announced our exit in LIVE MARKET.....

PVR was mentioned as an intraday pi...
Read more...
3
Reply
D
Reputation: 3,078 • Jan 18 8:59 AM
Dharun Invester in CIPLA
#CIPLA 810 call 20.60 to 27.15
2
Reply
D
Reputation: 3,078 • Jan 18 8:58 AM

#CIPLA 810 call 20.60 to 27.15
Like
Reply

Cipla stbt cmp 801-802 sl 815 #CIPLA
Like
Reply (1)
See all replies
Abdan Hatim @abdan
Jan 19 11:15 AM

Sl hit
D
Reputation: 3,078 • Jan 18 8:14 AM

Type
Buy
Instrument
CIPLA JAN21 810 PE
Entry Price
₹21.65
Price@Trade
₹21.65
Target Price
₹25
Stop Price
₹19
Valid Till
Jan 18, 2021 3:20 AM
Margin
₹28,145 approx for 1300 Qty
Status
Exited
Exit Price
₹23.2
Net P&L
+₹2,015 (+7.16%)
2
Reply (1)
See all replies
Dharun Invester @dharun
Jan 18 8:21 AM

Update
Exited
Exit Price
₹23.2
Net P&L
+₹2,015 (+7.16%)
D
Reputation: 3,078 • Jan 18 8:11 AM

Type
Buy
Instrument
CIPLA JAN21 810 PE
Entry Price
₹22.05
Price@Trade
₹22.05
Target Price
₹26
Stop Price
₹20
Valid Till
Jan 18, 2021 3:20 AM
Margin
₹28,665 approx for 1300 Qty
Status
Exited
Exit Price
₹22.05
Net P&L
₹0 (0%)
Like
Reply (1)
See all replies
Dharun Invester @dharun
Jan 18 8:13 AM

Update
Exited
Exit Price
₹22.05
Net P&L
₹0 (0%)
H
Reputation: -9,699 • Jan 18 6:18 AM

Type
Buy
Instrument
CIPLA JAN21 700 PE
Entry Price
₹0.7  ₹1
Price@Trade
₹1.25
Target Price
₹5
Stop Price
₹0
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹1,300 approx for 1300 Qty
Status
Exited
Exit Price
₹0.55
Net P&L
-₹585 (-45%)
Like
Reply (4)
See all replies
Harshad @harshad-HJA2KLX0v
Jan 18 8:05 AM

Update
Entry Price Modified
Price @ Update
₹1.4
Original Entry Price
₹1.4
New Entry Price
1.0
TrackerBot @trackerbot
Jan 19 2:47 AM

Update
Trade Entered
Entry Price
₹1
Harshad @harshad-HJA2KLX0v
Yesterday 3:33 AM

Update
Exited
Exit Price
₹0.55
Net P&L
-₹585 (-45%)
E
Reputation: 8,871 • Jan 18 3:54 AM

Type
Buy
Instrument
CIPLA JAN21 790 PE
Entry Price
₹15.75
Price@Trade
₹15.75
Target Price
₹25
Stop Price
₹14.5
Valid Till
Jan 18, 2021 3:20 AM
Margin
₹1,023,750 approx for 65000 Qty
Status
Exited
Exit Price
₹16.9
Net P&L
+₹74,750 (+7.3%)
Like
Reply (1)
See all replies
Eshu @eshu
Jan 18 3:57 AM

Update
Exited
Exit Price
₹16.9
Net P&L
+₹74,750 (+7.3%)
J
Reputation: -29,086 • Jan 18 3:52 AM

Type
Buy
Instrument
CIPLA JAN21 820 PE
Entry Price
₹30.8
Price@Trade
₹30.8
Target Price
₹50
Stop Price
₹15
Valid Till
Jan 18, 2021 3:20 AM
Margin
₹80,080 approx for 2600 Qty
Status
Exited
Exit Price
₹27.7
Net P&L
-₹8,060 (-10.06%)
Like
Reply (1)
See all replies
John Marston @johnmarston
Jan 18 4:54 AM

Update
Exited
Exit Price
₹27.7
Net P&L
-₹8,060 (-10.06%)

Type
Sell
Instrument
CIPLA
Entry Price
₹804.6
Price@Trade
₹804
Target Price
₹793
Stop Price
₹815
Valid Till
Jan 18, 2021 3:20 AM
Margin
₹804,600 approx for 1000 Qty
Status
Validity Over
Exit Price
₹801.2
Net P&L
+₹3,400 (+0.42%)
Like
Reply (3)
See all replies
TrackerBot @trackerbot
Jan 18 3:51 AM

Update
Trade Entered
Entry Price
₹804.6
Dipak13 @dipak13
Jan 18 4:29 AM

Entered @ 803.05
TrackerBot @trackerbot
Jan 18 8:50 AM

Update
Validity Over
Exit Price
₹801.2
Net P&L
+₹3,400 (+0.42%)

Type
Buy
Instrument
CIPLA JAN21 810 PE
Entry Price
₹23.85
Price@Trade
₹23.85
Target Price
₹30
Stop Price
₹18  ₹26.9
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹31,005 approx for 1300 Qty
Status
Stoploss Hit
Exit Price
26.9
Net P&L
+₹3,965 (+12.79%)
Like
Reply (2)
See all replies

Update
Stoploss Trailed
Price @ Update
₹27.1
Original SL
₹18
New SL
26.9
TrackerBot @trackerbot
Jan 18 3:57 AM

Update
Stoploss Hit
Exit Price
26.9
K
Reputation: -2,588 • Jan 18 3:12 AM

Type
Buy
Instrument
CIPLA
Entry Price
₹810.25
Price@Trade
₹810.25
Target Price
₹850
Stop Price
₹791
Valid Till
Feb 18, 2021 3:20 AM
Margin
₹81,025 approx for 100 Qty
Status
Active
Like
Reply
K
Reputation: -2,588 • Jan 18 3:11 AM

Type
Buy
Instrument
CIPLA
Entry Price
₹808.65
Price@Trade
₹808.65
Target Price
₹850
Stop Price
₹791
Valid Till
Feb 18, 2021 3:20 AM
Margin
₹808.65 approx for 1 Qty
Status
Active
Like
Reply
S
Reputation: 109 • Jan 18 3:07 AM

Type
Sell
Instrument
CIPLA
Entry Price
₹808
Price@Trade
₹808
Target Price
₹795
Stop Price
₹812
Valid Till
Jan 18, 2021 3:20 AM
Margin
₹24,240 approx for 30 Qty
Status
Stoploss Hit
Exit Price
₹812
Net P&L
-₹120 (-0.5%)
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Jan 18 3:15 AM

Update
Stoploss Hit
Exit Price
₹812
S
Reputation: 109 • Jan 18 3:02 AM

Type
Sell
Instrument
CIPLA
Entry Price
₹813.65
Price@Trade
₹813.65
Target Price
₹809
Stop Price
₹817
Valid Till
Jan 18, 2021 3:20 AM
Margin
₹24,409.5 approx for 30 Qty
Status
Exited
Exit Price
₹810.3
Net P&L
+₹100.5 (+0.41%)
Like
Reply (1)
See all replies
Sri @sri-rJ9qhjr2D
Jan 18 3:03 AM

Update
Exited
Exit Price
₹810.3
Net P&L
+₹100.5 (+0.41%)
S
Reputation: 109 • Jan 18 2:57 AM

Type
Buy
Instrument
CIPLA
Entry Price
₹818
Price@Trade
₹818.65
Target Price
₹827
Stop Price
₹815
Valid Till
Jan 18, 2021 3:20 AM
Margin
₹24,540 approx for 30 Qty
Status
Exited
Exit Price
₹817.3
Net P&L
-₹21 (-0.09%)
Like
Reply (2)
See all replies
TrackerBot @trackerbot
Jan 18 2:58 AM

Update
Trade Entered
Entry Price
₹818
Sri @sri-rJ9qhjr2D
Jan 18 2:58 AM

Update
Exited
Exit Price
₹817.3
Net P&L
-₹21 (-0.09%)
K
Reputation: -2,588 • Jan 18 2:46 AM

Type
Buy
Instrument
CIPLA
Entry Price
₹824.5
Price@Trade
₹824.5
Target Price
₹850
Stop Price
₹806
Valid Till
Feb 18, 2021 3:20 AM
Margin
₹82,450 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹806
Net P&L
-₹1,850 (-2.24%)
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Jan 18 3:09 AM

Update
Stoploss Hit
Exit Price
₹806
D
Reputation: 1,416,570 • Jan 17 4:45 AM
DEC QTR 2020 PHARMA COMPANIES RESULT PREVIEW
DEC QTR 2020 PHARMA COMPANIES RESULT PREVIEW
YouTube
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • CIPLA - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization42,645.7
    Enterprise Value42,471.14
    Price to Earnings29.77
    Price to Book Value2.7
    Return on Capital Employed0.13
    Return on Equity0.1
    Face Value2
    Dividend Yield0.01
  • CIPLA - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    14-Dec-20Prabhudas LilladherBuy887
    14-Dec-20HDFC SecuritiesBuy940
    9-Nov-20Prabhudas LilladherHold836
    7-Nov-20HDFC SecuritiesBuy900
    13-Oct-20Prabhudas LilladherReduce657
    CIPLA Brokerage Price Target
  • CIPLA Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jan 21835839.3809812.75
    Jan 20822.5834.9822.3832.8
    Jan 19802.5825.4802.5822.45
    Jan 18822826.65796.2801.75
    Jan 15839844.9821823.7
  • CIPLA Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹829.36
    30 Day Moving Average₹813.38
    50 Day Moving Average₹787.86
    100 Day Moving Average₹773.69
    200 Day Moving Average₹702.06
  • CIPLA - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue11,39010,974.580.04
    Operating Profit2,1181,596.260.33
    Profit Before Tax1,9111,186.940.61
    Net Income1,469974.940.51
  • CIPLA - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds15,78214,1140.12
    Total Liabilities2,6373,497-0.25
    Total Assets18,41917,6100.05
  • CIPLA - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity1,1172,205.56-0.49
    Cash from Investing Activity-593-1,191.75-0.5
    Cash from Financing Activity-351-1,008.97-0.65
    Net Cash Flow1734.8434.74
  • CIPLA - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.080.06
    Return on Equity0.10.08
    Return on Capital Employed0.130.09
  • CIPLA - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.12
    3 Year CAGR Growth in Operating Profit0.08
    3 Year CAGR Growth in EBIDTA0.16
    3 Year CAGR Growth in Net Income0.24
    3 Yr CAGR Growth - Diluted EPS0.24
  • CIPLA - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.39
    5 Year CAGR Growth in Operating ProfitNA
    5 Year CAGR Growth in EBIDTA0.05
    5 Year CAGR Growth in Net Income-0.03
    3 Yr CAGR Growth - Diluted EPS-0.03
  • CIPLA - Recent News

    keyboard_arrow_down
    NewsBot
    Jan 18 4:48 AM
    Cipla Q3 PAT Seen Up 77.2% YoY To Rs. 351 Cr: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Jan 18 2:08 AM
    Cipla Q3 PAT Seen Up 73.2% YoY To Rs. 608.1 Cr: ICICI Direct
    Moneycontrol
    NewsBot
    Jan 11 1:11 AM
    Stocks in the news: TCS, DMart, Sobha, Cipla, SCI and Star Cement
    The Economic Times
    NewsBot
    Jan 10 5:46 AM
    Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US
    The Economic Times
    NewsBot
    Dec 31, 2020 8:18 AM
    Will Normalcy Return To COVID-hit Indian Pharmaceutical Market In 2021?
    Moneycontrol
    NewsBot
    Dec 22, 2020 6:58 AM
    Quant Pick - Cipla: ICICI Direct
    Moneycontrol
    NewsBot
    Dec 22, 2020 5:11 AM
    Buy Cipla, target price Rs 965: ICICI Direct
    The Economic Times
    NewsBot
    Dec 16, 2020 4:58 AM
    Cipla Partners Premier Medical Corporation To Launch COVID-19 Rapid Antigen Test Kits In India
    Moneycontrol
    NewsBot
    Dec 16, 2020 4:51 AM
    Cipla partners Premier Medical Corporation to launch COVID-19 rapid antigen test kits in India
    The Economic Times
    NewsBot
    Dec 16, 2020 4:03 AM
    Cipla Share Price Gains On Launching Rapid Antigen Detection Test
    Moneycontrol
  • CIPLA - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
    Apollo Hospitals Enterprise Ltd. NSE:...
  • CIPLA - More Information

    keyboard_arrow_down

    Cipla Ltd:
    Cipla Limited, along with its multiple subsidiaries, is responsible for the manufacture and sale of pharmaceutical goods in India. It provides a variety of formulations and active pharmaceutical ingredients in various aspects like urology, ophthalmology, malaria, oncology, neurosciences, women’s and children’s health, hepatitis, critical care, osteoporosis, and infectious diseases.
    The company provides multiple inhalation therapy devices like nasal sprays, metered-dose inhalers, accessory devices, dry powder inhalers, and nebulizers. Apart from manufacturing and selling these products in India, it also exports to Russia, the Middle East, Asia, Australia, New Zealand, and Latin America and other regions internationally.
    On 17th of August in 1935, Cipla got registered as a public limited with a capital of Rs. 6 lakh and is a Mumbai based Company in India. During the Second World War, when the drug supplies were topped in 1941, the company started to produce fine chemicals. At this point, Cipla dedicated its facilities to provide a variety of ingenious drugs.
    About Company Information:
    Within the next two decades after the inception of the Second World War, in 1960, the company started its operations in Vikhroli, Mumbai. This was their second plant. At this unit, they produced fine chemicals related to natural products. Ampicillin was manufactured for the first time in the country in 1968 by Cipla. To cultivate medicinal plants, the company then started their Agricultural Research Division, located in Bangalore, in the year 1972.
    In 1982, the company started operating in its fourth manufacturing unit located in Patalganga, Maharashtra. The company collaborated with the National Chemical Laboratory in Pune, in the year 1984 to produce anti-cancer drugs like vincristine and vinblastine. Collaborating with Indian Institute of Chemical Technology, in 1991, a drug considered to be a breakthrough in chemotherapy, named etoposide was launched by the company. Later on, an antiretroviral drug called zidovudine was also manufactured by the company in association with Indian Institute of Chemical Technology.
    Nevirapine, an antiretroviral drug used to stop AIDS transmission in a child from a mother, was launched by the company in 1999. Cipla was the first company, outside of Europe and U.S.A, which began CFC-free-inhalers, in the year 2000. In February in 2007, the company allied with the Drugs for Neglected Diseases Initiative for developing a new anti-malarial drug. This was a worldwide initiative taken by the company with a non-profit organization like DNDI.
    In April of 2010, the company started its operations for commercial production of a variety of pharmaceutical formulations at their SEZ project in Indore, MP. On the 21st of July, 2012, Cipla revealed that they were to collaborate with DNDi (a non-profit R&D organization) for developing an improved form of antiretroviral (ARV) combo therapy which will specifically treat kids affected by HIV/AIDS.
    On the 17th of April, 2013, Cipla announced that they would be the first to launch a biosimilar of Etanercept in the country which will be targeted to treat rheumatic disorders. On the 20th of February in 2014, Cipla announced their alliance with MSD which would give them a non-exclusive license using which they would sell raltegravir 400mg tablet (a drug from MSD) along with marketing and distribution of the drug but down under a different brand name.
    In February 2015, Cipla revealed to have been awarded a Global Fund ARV Tender which is worth USD 188.95 million for developing antiretroviral drugs.
    On the 12th of October, 2016, Cipla announced the formal closing of US FDA inspection that was conducted in July-August in the year 2015. Cipla was given the establishment inspection report by the FDA, and it was held AT THE Indore Unit of the company. On the 30th of November, 2017, Cipla publicized the fact that the company had received approval from the World Health Organization (WHO) for a product name Q-TIB, which is essentially a combination of novel fixed-dose within a single tablet form. This was the first combination to ever exist in the world.
    How Cipla Ltd, is categorised as a Pharmaceutical and Healthcare Sector, and Pharmaceutical Industry :
    The Pharmaceutical Industry includes companies that derive their business by researching, discovering, developing, manufacturing, and marketing and distributing pharmaceutical medicines and drugs.
    Cipla Ltd is categorized under the Health care sector and Hospitals and Medical services Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
    The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
    Cipla Ltd, Competitors and Sector Peers:
    Abbott India Ltd. ABBIND
    Alembic Ltd. ALELTD
    Alembic Pharmaceuticals Ltd. ALEPHA
    Alkem Laboratories Ltd. ALKLAB
    Alpa Laboratories Ltd. ALPLAB
    Ambalal Sarabhai Enterprises Ltd. AMBSAR
    AstraZeneca Pharma India Ltd. ASTZEN
    Bafna Pharmaceuticals Ltd. BAFPHA
    Bajaj Healthcare Ltd. BAJHEA
    Biocon Ltd. BIOLTD
    Cian Healthcare Ltd.
    Cipla Ltd. CIPLTD
    Concord Drugs Ltd. CONDRU
    Dishman Pharmaceuticals & Chemicals Ltd.[Merged] DISPHA
    Divi's Laboratories Ltd. DIVIL
    Dr. Reddy's Laboratories Ltd. DR
    GlaxoSmithKline Pharmaceuticals Ltd. GLAPHA
    Glenmark Pharmaceuticals Ltd. GLEPHL
    IOL Chemicals and Pharmaceuticals Ltd. IOLCHE
    Lincoln Pharmaceuticals Ltd. LINPHA
    Lupin Ltd. LUPLTD
    Madhuveer Com 18 Network Ltd. TOHPHA
    Mahavir Advanced Remedies Ltd. INDAME
    Makers Laboratories Ltd. MAKLAB
    Natco Pharma Ltd. NATPHA
    Natural Capsules Ltd. NATCAP
    Ranbaxy Laboratories Ltd. RANLAB
    Sanofi India Ltd. AVEPHA
    Sharon Bio-Medicine Ltd. SHAPHA
    Sun Pharmaceutical Industries Ltd. SUN28
    Zenith Healthcare Ltd. ZENHEA
    Zyden Gentec Ltd. ZYDGEN
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020